JJL-73904-85758 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-07
Registered in v-safe
2021-04-07
Dose 1 — Janssen/Johnson & Johnson
2021-04-07
Survey response — day 0, dose 1
MedDRA: Paraesthesia, Sensitive skin — Feeling: Poor · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Pins and needles, skin sensitivity

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-13
Survey response — days 1–6 daily, dose 1
MedDRA: Heavy menstrual bleeding — Feeling: Fair · Fatigue or tiredness, Abdominal pain

Free text: Abnormally heavy menstruation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — day 7, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-21
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-28
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-05-05
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-05-12
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-05-23
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-07-07
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-10-08
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2021-10-28
Dose 2 — Moderna
2021-10-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-10-31
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-11-11
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-18
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-11-25
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-12-02
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-12-09
Survey response — day 42, dose 2
MedDRA: Fatigue, Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activities

Free text: Sore throat, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-04-28
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-10-28
Survey response — 12 months, dose 2
MedDRA: Angioedema, Chronic spontaneous urticaria — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Chronic idiopathic urticaria, angioedema.

MedDRA releases: 2024-11 · check-in free text available
2022-10-28
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2022-10-31
Call 1 — Requested Callback
2022-11-02
Call 2 — Left Voicemail
2022-11-02
Callback requested for

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-07	Janssen/Johnson & Johnson
2	2021-10-28	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-07

Systemic reaction (other): Pins and needles, skin sensitivity

Release 7 — days 1–6 daily, dose 1

2021-04-13

Systemic reaction (other): Abnormally heavy menstruation

Release 10 — day 42, dose 2

2021-12-09

Symptoms: Sore throat, fatigue

Release 12 — 12 months, dose 2

2022-10-28

Symptoms: Chronic idiopathic urticaria, angioedema.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Angioedema	·	·	✓
SD	Chronic spontaneous urticaria	·	·	✓
SD	Fatigue	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SRO	Heavy menstrual bleeding	✓	✓	✓
SRO	Paraesthesia	✓	✓	✓
SRO	Sensitive skin	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release